En

EFMC Grants

EFMC Grants 2020: Applications are open!

EFMC is funding grants for EFMC organised events with the aim to support the participation of young academic scientists.

Upon application, a limited number of grants will be covered by EFMC, corresponding to:

  • The full registration fees for EFMC-ISMC, EFMC-ASMC, ACSMEDI-EFMC Medicinal Chemistry Frontiers
  • Up to 50% of the registration fees for the EFMC Short Courses or the EFMC Accredited School

Please be informed that following new EFMC regulations, only the members of an EFMC National Adhering Organisation will be allowed to apply for the EFMC grants.

Grant applications for 2020 events are open!

  • 7th EFMC Young Medicinal Chemist Symposium (EFMC-YMCS 2020) 
    September 10-11, 2020 - Basel, Switzerland 
    Combined with the grant application of EFMC-ISMC 2020 (Participation to both events is required) 

Important remark: A grant application does not automatically register you to the conference. If your grant application is accepted, you will have to register to the conference, and submit your abstract again. If you wish to be considered for an Oral Communication at the EFMC-ISMC, you will have to register to the conference before April 2. In case your grant application is refused, free cancelation will be possible. 

EFMC Grants 2019

In 2019, the following grants have been distributed:

15th EFMC Short Course in Medicinal Chemistry

  • Dr Ornella DI PIETRO, UNIVERSITY OF CAMBRIDGE (United Kingdom)

EFMC-ACSMEDI MedChem Frontiers 2019

  • Dr Chiara BORSARI, UNIVERSITY OF BASEL (Switzerland)
  • Dr Sebastiano INTAGLIATA, UNIVERSITY OF FLORIDA (United States)
  • Mr Gustavo DA SILVA, FACULDADE DE FARMÁCIA DA UNIVERSIDADE DE LISBOA (Portugal)
  • Ms Erofili GIANNAKOPOULOU, NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS (Greece)
  • Dr Stefano SAINAS, UNIVERSITA DEGLI STUDI DI TORINO (Italy)

EFMC-ASMC'19 - EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry

  • Mr Niccolò CHIARAMONTE, UNIVERSITY OF FLORENCE (Italy)
  • Dr Margarida Leonor Florindo ESPADINHA, IMED.ULISBOA (Portugal)
  • Dr Jelena KONSTANTINOVIC, HELMHOLTZ INSTITUTE FOR PHARMACEUTICAL RESEARCH SAARLAND (HIPS) (Germany)
  • Ms Vanesa NOZAL GARCÍA, CENTRO DE INVESTIGACIONES BIOLÓGICAS-CSIC (Spain)
  • Dr Charles SKARBEK, UNIVERSITÉ PARIS SUD (France)